Phosphoenolpyruvate carboxykinase in cell metabolism: Roles and mechanisms beyond gluconeogenesis

Background: Phosphoenolpyruvate carboxykinase (PCK) has been almost exclusively recognized as a critical enzyme in gluconeogenesis, especially in the liver and kidney. Accumulating evidence has shown that the enhanced activity of PCK leads to increased glucose output and exacerbation of diabetes, wh...

Full description

Saved in:
Bibliographic Details
Main Authors: Shuo Yu (Author), Simin Meng (Author), Meixiang Xiang (Author), Hong Ma (Author)
Format: Book
Published: Elsevier, 2021-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_bbf18c88c61a4404a1cc0aabbd27c30d
042 |a dc 
100 1 0 |a Shuo Yu  |e author 
700 1 0 |a Simin Meng  |e author 
700 1 0 |a Meixiang Xiang  |e author 
700 1 0 |a Hong Ma  |e author 
245 0 0 |a Phosphoenolpyruvate carboxykinase in cell metabolism: Roles and mechanisms beyond gluconeogenesis 
260 |b Elsevier,   |c 2021-11-01T00:00:00Z. 
500 |a 2212-8778 
500 |a 10.1016/j.molmet.2021.101257 
520 |a Background: Phosphoenolpyruvate carboxykinase (PCK) has been almost exclusively recognized as a critical enzyme in gluconeogenesis, especially in the liver and kidney. Accumulating evidence has shown that the enhanced activity of PCK leads to increased glucose output and exacerbation of diabetes, whereas the defects of PCK result in lethal hypoglycemia. Genetic mutations or polymorphisms are reported to be related to the onset and progression of diabetes in humans. Scope of review: Recent studies revealed that the PCK pathway is more complex than just gluconeogenesis, depending on the health or disease condition. Dysregulation of PCK may contribute to the development of obesity, cardiac hypertrophy, stroke, and cancer. Moreover, a regulatory network with multiple layers, from epigenetic regulation, transcription regulation, to posttranscription regulation, precisely tunes the expression of PCK. Deciphering the molecular basis that regulates PCK may pave the way for developing practical strategies to treat metabolic dysfunction. Major conclusions: In this review, we summarize the metabolic and non-metabolic roles of the PCK enzyme in cells, especially beyond gluconeogenesis. We highlight the distinct functions of PCK isoforms (PCK1 and PCK2), depict a detailed network regulating PCK's expression, and discuss its clinical relevance. We also discuss the therapeutic potential targeting PCK and the future direction that is highly in need to better understand PCK-mediated signaling under diverse conditions. 
546 |a EN 
690 |a Phosphoenolpyruvate carboxykinase (PCK) 
690 |a Gluconeogenesis 
690 |a Glyceroneogenesis 
690 |a Transcription regulation 
690 |a Posttranscription regulation 
690 |a Epigenetic regulation 
690 |a Internal medicine 
690 |a RC31-1245 
655 7 |a article  |2 local 
786 0 |n Molecular Metabolism, Vol 53, Iss , Pp 101257- (2021) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S2212877821001022 
787 0 |n https://doaj.org/toc/2212-8778 
856 4 1 |u https://doaj.org/article/bbf18c88c61a4404a1cc0aabbd27c30d  |z Connect to this object online.